The Promise of Piperine in Cancer Chemoprevention
Overview
Authors
Affiliations
Cancer, characterized by the unregulated growth and dissemination of malignantly transformed cells, presents a significant global health challenge. The multistage process of cancer development involves intricate biochemical and genetic alterations within target cells. Cancer chemoprevention has emerged as a vital strategy to address this complex issue to mitigate cancer's impact on healthcare systems. This approach leverages pharmacologically active agents to block, suppress, prevent, or reverse invasive cancer development. Among these agents, piperine, an active alkaloid with a wide range of therapeutic properties, including antioxidant, anti-inflammatory, and immunomodulatory effects, has garnered attention for its potential in cancer prevention and treatment. This comprehensive review explores piperine's multifaceted role in inhibiting the molecular events and signaling pathways associated with various stages of cancer development, shedding light on its promising prospects as a versatile tool in cancer chemoprevention. Furthermore, the review will also delve into how piperine enhances the effectiveness of conventional treatments such as UV-phototherapy and TRAIL-based therapy, potentially synergizing with existing therapeutic modalities to provide more robust cancer management strategies. Finally, a crucial perspective of the long-term safety and potential side effects of piperine-based therapies and the need for clinical trials is also discussed.
Es-Sai B, Wahnou H, Benayad S, Rabbaa S, Laaziouez Y, El Kebbaj R Molecules. 2025; 30(3).
PMID: 39942758 PMC: 11821177. DOI: 10.3390/molecules30030653.
Wiraswati H, Maruf I, Hidayati N, Ramadhanti J, Calina D, Sharifi-Rad J Discov Oncol. 2025; 16(1):10.
PMID: 39760812 PMC: 11704108. DOI: 10.1007/s12672-024-01716-4.
Rajendran P, Renu K, Ali E, Genena M, Veeraraghavan V, Sekar R Immun Inflamm Dis. 2024; 12(10):e70041.
PMID: 39436197 PMC: 11494898. DOI: 10.1002/iid3.70041.
Nature's weapons: Bioactive compounds as anti-cancer agents.
Auti A, Tathode M, Marino M, Vitiello A, Ballini A, Miele F AIMS Public Health. 2024; 11(3):747-772.
PMID: 39416904 PMC: 11474324. DOI: 10.3934/publichealth.2024038.
Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action.
Talib W, Baban M, Bulbul M, Al-Zaidaneen E, Allan A, Al-Rousan E Int J Mol Sci. 2024; 25(17).
PMID: 39273552 PMC: 11394730. DOI: 10.3390/ijms25179593.